Allergan: Q1 Results Could Convince Bulls Growth Is Dead

Allergan: Q1 Results Could Convince Bulls Growth Is Dead


Allergan reports quarterly earnings Monday April 30th. Investors expect revenue of $3.59 billion and eps of $3.35.



from Biotech News